Literature DB >> 17171315

Clinical features of scleroderma patients with contracture of phalanges.

Ryuichi Ashida1, Hironobu Ihn, Yoshihiro Mimura, Masatoshi Jinnin, Yoshihide Asano, Masahide Kubo, Kunihiko Tamaki.   

Abstract

Contracture of phalanges (CP) is a frequent complication of patients with systemic sclerosis (SSc). The objective of this study was to examine the prevalance of CP in patients with SSc and investigate the clinical and laboratory features of SSc patients with CP. Three hundred and fifty patients with SSc were examined. CP was found in 164 of the 350 patients (47%) with SSc. The prevalence of oesophageal involvement, pulmonary fibrosis or heart involvement was significantly greater in the patients with CP than that in those without CP. Our study suggested that the presence of CP may be a marker of oesophageal involvement, pulmonary fibrosis and heart involvement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171315     DOI: 10.1007/s10067-006-0490-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Erosive arthropathy in systemic scleroderma.

Authors:  W Wild; W P Beetham
Journal:  JAMA       Date:  1975-05-05       Impact factor: 56.272

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  Early fingertip changes in scleroderma.

Authors:  H Y Yune; V A Vix; E C Klatte
Journal:  JAMA       Date:  1971-02-15       Impact factor: 56.272

4.  Synovial tissue changes and rheumatoid factor in scleroderma.

Authors:  J A Clark; R K Winkelmann; F C McDuffie; L E Ward
Journal:  Mayo Clin Proc       Date:  1971-02       Impact factor: 7.616

5.  Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

Authors:  V D Steen; D L Powell; T A Medsger
Journal:  Arthritis Rheum       Date:  1988-02

6.  Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis.

Authors:  S Sato; H Ihn; K Kikuchi; K Takehara
Journal:  Arthritis Rheum       Date:  1994-03

7.  Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis.

Authors:  H Ihn; K Yamane; N Yazawa; M Kubo; M Fujimoto; S Sato; K Kikuchi; K Tamaki
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

8.  Clinical and laboratory features of scleroderma patients with pulmonary hypertension.

Authors:  K Yamane; H Ihn; Y Asano; N Yazawa; M Kubo; K Kikuchi; Y Soma; K Tamaki
Journal:  Rheumatology (Oxford)       Date:  2000-11       Impact factor: 7.580

9.  Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis.

Authors:  V D Steen; G L Ziegler; G P Rodnan; T A Medsger
Journal:  Arthritis Rheum       Date:  1984-02

10.  Antinuclear antibodies and anti-DNA antibodies in scleroderma. A possible relationship between joint manifestations and increased antibodies in localized scleroderma.

Authors:  J Serup; P Staun-Olsen
Journal:  Allergy       Date:  1986-08       Impact factor: 13.146

View more
  5 in total

1.  Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment.

Authors:  Amber Young; Rajaie Namas; Carole Dodge; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-07-19

2.  Evaluation of limited hand mobility in systemic sclerosis patients by using "prayer sign" and "tabletop sign".

Authors:  Sadettin Uslu; Semih Gülle; Gerçek Can; İsmail Sarı; Fatoş Önen; Merih Birlik
Journal:  Clin Rheumatol       Date:  2021-02-08       Impact factor: 2.980

3.  Evaluating hand in systemic sclerosis.

Authors:  Didem Arslan Tas; Eren Erken; Hakan Sakalli; A Eftal Yucel
Journal:  Rheumatol Int       Date:  2011-11-17       Impact factor: 2.631

4.  Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: A systematic review and meta-analysis.

Authors:  Meihua Qiu; Xueyuan Nian; Lingling Pang; Pengfei Yu; Shenchun Zou
Journal:  Int J Rheum Dis       Date:  2021-08-21       Impact factor: 2.558

5.  Pain and Self-Efficacy Among Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.

Authors:  Robyn K Wojeck; Susan G Silva; Donald E Bailey; Mitchell R Knisely; Linda Kwakkenbos; Marie-Eve Carrier; Warren R Nielson; Susan J Bartlett; Janet Pope; Brett D Thombs
Journal:  Nurs Res       Date:  2021 Set/Oct 01       Impact factor: 2.381

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.